Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Rhonda Rhyne, Perry Fell, Conrad Mir


Proteomics-based diagnostics developer Prevencio has appointed H. Perry Fell to be chairman of the board and Rhonda Rhyne to be president, CEO, and board director.

Fell formerly was chairman and CEO of NanoString Technologies and he co-founded Seattle Genetics. Rhyne has been president of CardioDynamics, and she founded the consulting company Rhyne Life Sciences.

Pressure BioSciences said this week that Chief Financial Officer Conrad Mir has resigned from his post, effective immediately. He has been named CEO of Competitive Technologies (CTI), a biotech firm that distributes a pain therapy medical device, CTI said separately this week.

Pressure Bio has named Richard Thomley to serve as the firm's acting CFO. Thomley has been an independent financial consultant to the company since March.